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This editorial refers to ‘Dominant-negative effect of SCN5A
N-terminal mutations through the interaction of Nav1.5
a-subunits’ by J. Clatot et al., pp. 53–63, this issue.
The field of cardiac channelopathies, i.e. dysfunction of ion channels
caused by genetic defects, is one of the most fascinating areas of re-
search for modern biomedical scientists. Indeed, these studies enable
us to understand how a single genetic and molecular defect that can
be recorded in one molecule, such as the bursting behaviour of one
Nav1.5 long QT syndrome (LQTS) mutant channel,
1 may lead to
sudden cardiac death.2 Since 1995, this field has benefited from a pro-
lific, interdisciplinary community of clinicians, geneticists, biophysicists,
and biologists,3 as is the case in the study by Clatot et al.4 published in
this issue of Cardiovascular Research. Among the most striking exam-
ples is congenital LQTS, with hundreds of mutations found in a
total of 13 genes. The LQTS genes KCNQ1 and KCNH2 code for
the a-subunits of the K+ ion channels that are responsible for the
IKs and IKr repolarizing cardiac currents.
3 Genetic investigations have
shown that most LQTS patients are carriers of a single mutated
allele consistent with dominant transmission of the pathological trait.5
Early studies on LQTS missense mutations of KCNQ16 have demon-
strated a dominant negative effect of the mutant a-subunits, which is
consistent with the multimeric nature of voltage-gated K+ channels.
Epidemiological studies7 subsequently demonstrated the worse
outcome of patients carrying missense KCNQ1 mutations, exerting a
dominant negative effect, when compared with individuals having non-
sense mutations that lead to haploinsufficiency.
In the case of mutations in the gene SCN5A, which codes for the
pore-forming a-subunit of the voltage-gated cardiac Na+ channel
Nav1.5, hundreds of genetic variants have been found in patients
with a long list of cardiac manifestations.8 Among them, the
Brugada syndrome (BrS) is an interesting case. This syndrome was
first described in 19929 in patients suffering from syncope and
sudden cardiac death caused by ventricular arrhythmias with a pecu-
liar elevation of the ST-segment in the right precordial leads of the
electrocardiogram. Mutations in SCN5A were found in BrS patients
in 1998,10 and since then, the description of hundreds of SCN5A muta-
tions has followed. Note that the question of the direct causality of
these SCN5A mutants is still under debate.11 Nevertheless, it is
clear that a large number of the SCN5A variants found in BrS lead
to loss-of-function of Nav1.5 when expressed in cellular expression
systems.12 The mutations found in BrS are mostly missense, nonsense,
and frame-shift mutations. Variants with missense mutations often
show evidence of misfolding of the mutant proteins and altered traf-
ficking with retention in the endoplasmic reticulum of expressing cells.
Here, one should add a word of caution, since most of these findings
were obtained using cellular expression systems and not native
tissues.
In 2005, our group studied two SCN5A BrS mutations.13 One was a
nonsense mutation, p.R535X, and the other was a missense mutation,
p.L325R. Both variants, expressed in HEK293 cells, displayed a marked
decrease in Na+ current. With the aim of mimicking the heterozygous
state of the patients, we then co-expressed (using similar amounts of
cDNA) the wild-type (WT) and the p.L325R variants in HEK293 cells
and observed that the Na+ current was disproportionately reduced
(i.e. a larger reduction than if only the same amount of WT allele
was expressed). This phenomenon was not observed with the non-
sense p.R535X mutation. This was the first demonstration that a
mutant Nav1.5 protein may have a dominant-negative effect on the
function of the WT subunit, and it raised the obvious question
about the molecular mechanism underlying this surprising observa-
tion. Indeed, unlike K+ channels which function as multimers, Na+
channel multimerization had so far never been suspected, since the
pore-forming a-subunit of Nav1.5 is found in a single polypeptide.
This notion was first put into question with the provocative results
from the Descheˆnes group, suggesting that Nav1.5 channels,
encoded by different alleles, may biochemically and functionally
interact.14
In this issue of Cardiovascular Research, the groups of Neyroud and
Descheˆnes convincingly confirm these early observations and provide
further molecular insights into the interaction between the a-subunits
of the cardiac Na+ channels.4 First, they investigated two BrS muta-
tions found in the N-terminus of Nav1.5 (p.R104W and p.R121W)
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Figure 1 Proposed trafficking processes in HEK293 that depend upon transfection conditions; based on the findings of Clatot et al.4 From left to
right: under normal conditions, after the synthesis of the WT Nav1.5 channel (green channel), single channels stay in the endoplasmic reticulum (ER).
Interaction between two Nav1.5 channel N-termini (depicted by the blue arrowheads) allows the complex to be targeted to the plasma membrane
through the cis- and trans-Golgi apparatus. Under dominant-negative conditions, the complex of WT and mutant Nav1.5 channels (red channel) is
mainly retained in the ER. In contrast to WT channels, mutant channels can be degraded by the proteasomal and/or the lysosomal pathways
(orange arrows). Only a few WT channels interacting together reach the plasma membrane compared with the situation under normal conditions.
In the case of expression of mutant channels only, the complex, due to the interaction between two N-termini of mutant channels, is mainly degraded
by the proteasomal and/or lysosomal pathways (orange arrows). Interaction of an N-terminal part overexpressed in HEK293 cells (yellow) of the WT
Nav1.5 channel with full-length WT channels increases the number of channels at the plasma membrane (thick blue arrows) in comparison with
normal conditions. The mechanisms underlying this observation may rely on the masking of an ER retention motif in the N-terminus of the channel.
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and clearly observed that the mutants, when co-expressed with the
WT channel, had a dominant-negative effect on the Na+ current
(Figure 1). They then obtained evidence suggesting a crucial role of
the N-terminus domain of Nav1.5 in this phenomenon (by studying
an N-terminally truncated WT channel) and also showed that overex-
pression of only the N-terminus of WT channel in HEK293 cells led
to a doubling of the Na+ current. Lastly, they were able to show that
Nav1.5 subunits could be co-immunoprecipitated, thus strongly sug-
gesting an interaction in the cells that could be dependent on the
N-termini (Figure 1).
The main conclusion of these recent studies is that, unexpectedly,
a dominant-negative phenomenon can also be observed by
co-expressing different cDNAs of Nav1.5 in cellular expression
systems. These important findings clearly need to be further inves-
tigated since, as is often the case, they raise more questions than
we had before knowing them. What are the details of the cellular
and biochemical mechanisms leading to the reduced expression of
the WT Nav1.5 channels at the cell surface? What is the nature
of proposed interactions between the N-termini? Will future exam-
inations reveal that BrS patients, who harbour such dominant-
negative variants, tend to display more severe phenotypes than
the ones with nonsense mutations leading to haploinsufficiency?
And finally, will we be able to translate these findings into clinical
management of BrS patients by refining risk stratification and devis-
ing new therapeutic strategies?
Lastly, one of the main lessons of these studies is that one should
‘be prepared to expect the unexpected’!
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